These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 428828)

  • 81. [Not Available].
    Wennevik GE; Vangedal M
    Ugeskr Laeger; 2022 Dec; 184(51):. PubMed ID: 36621877
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Christmas article: Goose breast caused by unusual circumstances].
    Henriksen JH
    Ugeskr Laeger; 2022 Dec; 184(50):. PubMed ID: 36510805
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Reversible gynaecomastia associated with etritinate.
    Carmichael AJ; Paul CJ
    Br J Dermatol; 1989 Feb; 120(2):317. PubMed ID: 2923800
    [No Abstract]   [Full Text] [Related]  

  • 84. Omeprazole-induced galactorrhea in kidney transplant patients-a case report.
    Dorji C; Robin FA; Na-Bangchang K
    J Med Case Rep; 2022 Mar; 16(1):121. PubMed ID: 35339194
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review.
    Patel H; Arruarana V; Yao L; Cui X; Ray E
    Endocrine; 2020 Apr; 68(1):6-15. PubMed ID: 32067157
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Vitamin B
    Beltrame FL; de Santi F; Vendramini V; Cabral REL; Miraglia SM; Cerri PS; Sasso-Cerri E
    Front Endocrinol (Lausanne); 2019; 10():309. PubMed ID: 31354617
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Vitamin B
    Beltrame FL; Sasso-Cerri E
    Asian J Androl; 2017; 19(5):567-572. PubMed ID: 27568998
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gynecomastia and drugs: a critical evaluation of the literature.
    Nuttall FQ; Warrier RS; Gannon MC
    Eur J Clin Pharmacol; 2015 May; 71(5):569-78. PubMed ID: 25827472
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.
    Ito T; Igarashi H; Uehara H; Berna MJ; Jensen RT
    Medicine (Baltimore); 2013 May; 92(3):135-181. PubMed ID: 23645327
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs.
    García Rodríguez LA; Jick H
    BMJ; 1994 Feb; 308(6927):503-6. PubMed ID: 8136667
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Safety of acid-suppressing drugs.
    Smallwood RA; Berlin RG; Castagnoli N; Festen HP; Hawkey CJ; Lam SK; Langman MJ; Lundborg P; Parkinson A
    Dig Dis Sci; 1995 Feb; 40(2 Suppl):63S-80S. PubMed ID: 7859585
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Problems in the medical treatment of peptic ulcers.
    Wormsley KG
    J R Coll Physicians Lond; 1980 Jul; 14(3):169-72. PubMed ID: 7205728
    [No Abstract]   [Full Text] [Related]  

  • 93. Endocrine effects of acute and chronic cimetidine administration.
    Carlson HE; Ippoliti AF; Swerdloff RS
    Dig Dis Sci; 1981 May; 26(5):428-32. PubMed ID: 7018862
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.
    Müller EE; Locatelli V; Cella S; Peñalva A; Novelli A; Cocchi D
    Drugs; 1983 Apr; 25(4):399-432. PubMed ID: 6133737
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Use and abuse of H2 receptor antagonists.
    Hunt RH
    J R Coll Physicians Lond; 1982 Jan; 16(1):33-9. PubMed ID: 6121053
    [No Abstract]   [Full Text] [Related]  

  • 96. Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.
    Londong W; Londong V; Ruthe C; Weizert P
    Gut; 1981 Jul; 22(7):542-8. PubMed ID: 6114900
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The effects of ranitidine on pituitary-thyroid function.
    Hine KR; Harrop JS; Hopton MR; Holmes GK; Matthews HL
    Br J Clin Pharmacol; 1984 Oct; 18(4):608-11. PubMed ID: 6091713
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Plasma prolactin, sex steroids and gastrin in human volunteers treated for 2 weeks with therapeutic doses of cimetidine or the new histamine H2-receptor antagonist ramixotidine (CM 57755A).
    Colle M; Ruedas E; Cazenave J; Auzerie J; Basilisco G; Camboni G; Manara L
    Eur J Clin Pharmacol; 1988; 35(5):529-34. PubMed ID: 2906873
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Adverse reactions and interactions with H2-receptor antagonists.
    Penston J; Wormsley KG
    Med Toxicol; 1986; 1(3):192-216. PubMed ID: 2878343
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.